Used in targeted cancer therapies, particularly for cancers exhibiting overexpression of dysadherin, such as certain lung, gastric, and prostate cancers. This antibody inhibits tumor cell migration and invasion by blocking dysadherin-mediated pathways, thereby reducing metastasis. It is also employed in diagnostic applications to detect dysadherin in tumor tissues, aiding in cancer prognosis. Additionally, it serves as a research tool to study cell adhesion mechanisms and epithelial-mesenchymal transition in cancer progression.